A randomized, single-blind, placebo-controlled, parallel-group study evaluating the anti-inflammatory activity of GSK315234 in synovial biopsy tissue obtained from subjects with rheumatoid arthritis

Trial Profile

A randomized, single-blind, placebo-controlled, parallel-group study evaluating the anti-inflammatory activity of GSK315234 in synovial biopsy tissue obtained from subjects with rheumatoid arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2012

At a glance

  • Drugs GSK 315234 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Biomarker; Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2012 Additional trial location (Belgium) added as reported by European Clinical Trials Database record.
    • 28 Jun 2012 Planned end date changed from 16 Dec 2011 to 16 Sep 2011 as reported by European Clinical Trials Database record.
    • 15 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top